Anti-Glycated Albumin Therapy Ameliorates Early Retinal Microvascular Pathology in db/db Mice
Open Access
- 1 January 1998
- journal article
- research article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 12 (1) , 28-33
- https://doi.org/10.1016/s1056-8727(97)00051-2
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Receptor-Mediated Toxicity to Pericytes of Advanced Glycosylation End Products: A Possible Mechanism of Pericyte Loss in Diabetic MicroangiopathyBiochemical and Biophysical Research Communications, 1995
- Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcriptionMolecular and Cellular Biochemistry, 1995
- Amelioration of diabetic nephropathy by treatment with monoclonal antibodies against glycated albuminKidney International, 1994
- Amadori glucose adducts modulate mesangial cell growth and collagen gene expressionKidney International, 1994
- Binding sites for short-term glycated albumin on peritoneal cells of the ratBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Evaluation and performance characteristics of a novel ELISA using monoclonal antibody to glycated albuminClinica Chimica Acta; International Journal of Clinical Chemistry, 1989
- Studies on the Retina of the Diabetic db/db MouseOphthalmic Research, 1989
- Clinical Utility of Nonenzymatically Glycosylated Blood Proteins as an Index of Glucose ControlDiabetes Care, 1984
- Structural-functional relationships in diabetic nephropathy.Journal of Clinical Investigation, 1984
- RCapillaries: Basement Membrane Thickening by Galactosemia Prevented with Aldose Reductase InhibitorScience, 1983